... lung can-cer with epidermal growth factor receptor mutations. BrJ Cancer 95, 998–1004.16 Sutani A, Nagai Y, Udagawa K, Uchida Y, KoyamaN, Murayama Y, Tanaka T, Miyazawa H, Nagata M,Kanazawa ... 3340–3346.15 Asahina H, Yamazaki K, Kinoshita I, Sukoh N,Harada M, Yokouchi H, Ishida T, Ogura S, Kojima T,Okamoto Y et al. (2006) A phase II trial of gefitinib asfirst-line therapy for advanced non-small ... wereobtained in a retrospective analysis of a trial of pani-tumumab in patients with mCRC [5]. Panitumumab, a fully human mAb targeted to the extracellular domain of EGFR, is of the IgG2 isotype, and...